A single infusion of Zoledronic acid suppressed bone turnover markers for up to seven years: Results from the Zoledronate in the Prevention of Paget's disease (ZiPP) study

Jonathan Tang; William Fraser; Jonathan Phillips; Isabelle Piec; Rachel Dunn; Catriona Keerie; Steff Lewis; Stuart Ralston

doi:10.1530/endoabs.94.P31

A single infusion of Zoledronic acid suppressed bone turnover markers for up to seven years: Results from the Zoledronate in the Prevention of Paget's disease (ZiPP) study

Jonathan Tang, William Fraser, Jonathan Phillips, Isabelle Piec, Rachel Dunn, Catriona Keerie, Steff Lewis, Stuart Ralston

Research output: Contribution to conference › Abstract

Original language	English
DOIs	https://doi.org/10.1530/endoabs.94.P31
Publication status	Published - 2023

Access to Document

10.1530/endoabs.94.P31

Single Dose Zoledronic Acid Effective for Paget’s Prevention
Jonathan Tang
14/11/23
1 item of Media coverage
Press/Media: Press / Media

Cite this

@conference{99a8458ec71e441c820fb5065dd68ecb,

title = "A single infusion of Zoledronic acid suppressed bone turnover markers for up to seven years: Results from the Zoledronate in the Prevention of Paget's disease (ZiPP) study",

author = "Jonathan Tang and William Fraser and Jonathan Phillips and Isabelle Piec and Rachel Dunn and Catriona Keerie and Steff Lewis and Stuart Ralston",

year = "2023",

doi = "10.1530/endoabs.94.P31",

language = "English",

}

TY - CONF

T1 - A single infusion of Zoledronic acid suppressed bone turnover markers for up to seven years: Results from the Zoledronate in the Prevention of Paget's disease (ZiPP) study

AU - Tang, Jonathan

AU - Fraser, William

AU - Phillips, Jonathan

AU - Piec, Isabelle

AU - Dunn, Rachel

AU - Keerie, Catriona

AU - Lewis, Steff

AU - Ralston, Stuart

PY - 2023

Y1 - 2023

U2 - 10.1530/endoabs.94.P31

DO - 10.1530/endoabs.94.P31

M3 - Abstract

ER -

A single infusion of Zoledronic acid suppressed bone turnover markers for up to seven years: Results from the Zoledronate in the Prevention of Paget's disease (ZiPP) study

Access to Document

Press/Media

Single Dose Zoledronic Acid Effective for Paget’s Prevention

Cite this